Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Abstract 2600: AsiDNA® treatment protects healthy cells from anticancer treatment toxicity

Wael Jdey, Anouk Sesink, Agathe Cohendet, Juliette Rieu, Chloe Doizelet, Vincent Hayes, Pierre-Marie Girard, Marie Dutreix, Judith Greciet

Cancer Res (2022) 82 (12_Supplement): 2600.

DOI: https://doi.org/10.1158/1538-7445.AM2022-2600

Published: 15 June 2022

View article

Journal Articles

Abstract 2865: AsiDNA^TM, a novel DNA repair inhibitor to sensitize aggressive medulloblastoma subtypes

Sofia Ferreira, Chloe Foray, Sophie Heinrich, Celio Pouponnot, Marie Dutreix

Cancer Res (2019) 79 (13_Supplement): 2865.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2865

Published: 01 July 2019

View article

Journal Articles

Abstract 2918: Molecular analysis of the mechanism of action of AsiDNA^TM brings new clues on DNA damage response regulation

Nathalie Berthault, Kozlac Maria, Sergey Alekseev, Pierre-Marie Girard, Marie Dutreix

Cancer Res (2019) 79 (13_Supplement): 2918.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2918

Published: 01 July 2019

View article

Journal Articles

Abstract 2095: AsiDNA^TM, a targeted therapy with no acquired resistance

Wael Jdey, Maria Kozlac, Sergey Alekseev, Danielle Johnson, françoise Bono, Srividya bhaskara, frederic thomas, Marie Dutreix

Cancer Res (2019) 79 (13_Supplement): 2095.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2095

Published: 01 July 2019

View article

Journal Articles

Abstract 2130: Development of a biomarker-driven patient selection strategy for AsiDNA treatment

Wael Jdey, Donogh O'Brien, Richard Tripelon, Séverine Rochas, Marie Dutreix, Françoise Bono

Cancer Res (2019) 79 (13_Supplement): 2130.

DOI: https://doi.org/10.1158/1538-7445.AM2019-2130

Published: 01 July 2019

View article

Journal Articles

Abstract 2818: AsiDNA and HDAC inhibitors: A cross-potentiation team working to kill tumor cells

Wael Jdey, Hélène Toussaint, Coraline Cassegrain, Laura Bellassen, Richard Tripelon, Vincent Hayes, Perrine Pivette, Véronique Trochon-Joseph, Jean-Louis Labernardière, Marie Dutreix, Françoise Bono Colombie

Cancer Res (2018) 78 (13_Supplement): 2818.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2818

Published: 01 July 2018

View article

Journal Articles

Abstract 2851: The evolution of tumor cells under AsiDNA treatment results in “autosensitization”

Maria Kozlac, Wael Jdey, Pierre-Marie Girard, Françoise Bono, Marie Dutreix

Cancer Res (2018) 78 (13_Supplement): 2851.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2851

Published: 01 July 2018

View article

Journal Articles

Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA

Wael Jdey, Sylvain Thierry, Tatiana Popova, Marc-Henri Stern, Marie Dutreix

Cancer Res (2017) 77 (16): 4207–4216.

DOI: https://doi.org/10.1158/0008-5472.CAN-16-2693

Published: 14 August 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 1110: AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer

marie DUTREIX, Wael Jdey, sylvain Thierry, Inna Kuperstein, Graham Dixon

Cancer Res (2017) 77 (13_Supplement): 1110.

DOI: https://doi.org/10.1158/1538-7445.AM2017-1110

Published: 01 July 2017

View article

Journal Articles

Abstract 4483: Preclinical study of Dbait, an inhibitor of three DNA repair pathways, in breast cancer treatment.

Marie Dutreix, Youlia M. Kirova, Amelie Croset, Flavien Devun, Jian-Sheng Sun

Cancer Res (2013) 73 (8_Supplement): 4483.

DOI: https://doi.org/10.1158/1538-7445.AM2013-4483

Published: 15 April 2013

View article

Journal Articles

Spi-1/PU.1 Oncogene Accelerates DNA Replication Fork Elongation and Promotes Genetic Instability in the Absence of DNA Breakage

Pauline Rimmelé, Jun Komatsu, Philippe Hupé, Christophe Roulin, Emmanuel Barillot, Marie Dutreix, Emmanuel Conseiller, Aaron Bensimon, Françoise Moreau-Gachelin, Christel Guillouf

Cancer Res (2010) 70 (17): 6757–6766.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-4691

Published: 31 August 2010

View article

Includes: Supplementary data

Journal Articles

Gamma H2AX foci disorganization and anti-tumor activity by trapping DNA-PK with a double strand break mimicking agent

Jian-Sheng Sun, Jean-Marc Cosset, Marie Dutreix

Cancer Res (2007) 67 (9_Supplement): 1975.

Published: 01 May 2007

View article

NARROW

Abstract 2600: AsiDNA® treatment protects healthy cells from anticancer treatment toxicity

Abstract 2865: AsiDNA^TM, a novel DNA repair inhibitor to sensitize aggressive medulloblastoma subtypes

Abstract 2918: Molecular analysis of the mechanism of action of AsiDNA^TM brings new clues on DNA damage response regulation

Abstract 2095: AsiDNA^TM, a targeted therapy with no acquired resistance

Abstract 2130: Development of a biomarker-driven patient selection strategy for AsiDNA treatment

Abstract 2818: AsiDNA and HDAC inhibitors: A cross-potentiation team working to kill tumor cells

Abstract 2851: The evolution of tumor cells under AsiDNA treatment results in “autosensitization”

Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA

Abstract 1110: AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer

Abstract 4483: Preclinical study of Dbait, an inhibitor of three DNA repair pathways, in breast cancer treatment.

Spi-1/PU.1 Oncogene Accelerates DNA Replication Fork Elongation and Promotes Genetic Instability in the Absence of DNA Breakage

Gamma H2AX foci disorganization and anti-tumor activity by trapping DNA-PK with a double strand break mimicking agent

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only